Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme

By Banna Giuseppe   Bettio Daniela   Scorsetti Marta   Navarria Pierina   Simonelli Matteo   Rodriguez Baena Riccardo   Aimar Enrico   Gaetani Paolo   Colombo PierGiuseppe   Rognone Felice   Santoro Armando  

Journal of Neuro-Oncology, Vol. 81, Iss. 3, 2007-02 ,pp. : 323-325

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of temozolomide in children with recurrent high-grade glioma

By Ruggiero A.   Cefalo G.   Garré M.L.   Massimino M.   Colosimo C.   Attinà G.   Lazzareschi I.   Maurizi P.   Ridola V.   Mazzarella G.   Caldarelli M.   Rocco C.   Madon E.   Abate M.E.   Clerico A.   Sandri A.   Riccardi R.  

Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite

Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma

By Su Ying-Wen   Chang Ming-Chih   Chiang Ming-Fu   Hsieh Ruey-Kuen  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 315-318

Springer Publishing Company

Access to resources Recommend Favorite

A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study

By Hargrave Darren  

Journal of Neuro-Oncology, Vol. 113, Iss. 1, 2013-05 ,pp. : 127-134

Springer Publishing Company

Access to resources Recommend Favorite

Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide

By Monje Michelle   Ramakrishna Naren   Young Geoffrey   Drappatz Jan   Doherty Lisa   Wen Patrick   Kesari Santosh  

Journal of Neuro-Oncology, Vol. 84, Iss. 2, 2007-09 ,pp. : 179-183

Springer Publishing Company

Access to resources Recommend Favorite